Anti-APP Abeta重组抗体|科研级 Bapineuzumab ( 巴匹组单抗 )-Product Center-Tekbiotech-Yeast and Phage Display CRO, Expert in Nano-body and Antibody Drug Development

Anti-APP Abeta重组抗体|科研级 Bapineuzumab ( 巴匹组单抗 )

Detailed related information Target background information Experimental Plan&FAQ Related products Recommended Services

询价与订购

Name*
Phone*
Email*
Product*
Content*

Anti-APP Abeta重组抗体|科研级 Bapineuzumab ( 巴匹组单抗 )

instructions Contact

< >

CatNo：TKYR1164

Price

WeChat QR
Contact Us

instructions
MSDSWeChat QR
Contact Us

Detailed

Background

Plan&FAQ

Recommended

Detailed related information

Catalog Number

TKYR1164

Alias

科研级 Bapineuzumab ( 巴匹组单抗 ), Anti-APP Abeta Recombinant Antibody, Research Grade Bapineuzumab

Molecular Name

Bapineuzumab

Size

1mg, 5mg

CAS Number

648895-38-9

Isotype

IgG1

Clonality

Monoclonal

Concentration

1mg/ml

Applications

WB, FuncS, IF, Neut, ELISA, FC, IP

Source

CHO Cells

Purity

≥95% as determined by SDS-PAGE

Buffer

Supplied in PBS, PH7.5

Target

APP Abeta[Homo sapiens]

Sequence

Please contact our sales representative to learn more information about this reagents.

Background

Bapineuzumab (nicknamed "bapi") is a humanized monoclonal antibody that acts on the nervous system and may have potential therapeutic value for the treatment of Alzheimer's disease and possibly glaucoma. However, in 2012 it failed to produce significant cognitive improvements in patients in two major trials, despite lowering key biomarkers of AD, amyloid brain plaque and hyperphosphorylated tau protein in CSF.

Storage

该产品可在 2°C-8°C 下保存一个月，活性不会明显降低。在 -20°C 至 -80°C 下保存，可稳定保存十二个月。避免反复冻融,用冰袋运输。

NOTE

仅科研使用

Target background information

Experimental Plan&FAQ